Publication | Closed Access

Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice

Pulmonary Arterial HypertensionHeart FailurePulmonary CirculationCardiovascular DiseaseMedicinePhysiologyCardiovascular PharmacologyPulmonary PhysiologyPulmonary PharmacologyVascular BiologyPublic HealthPharmacologyCardiologyLeft Heart DiseasePulmonary Vascular DiseaseSodium-glucose Cotransporter 2